 Richard Hendrickson
Concepts (438)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 10 | 2023 | 47 | 4.160 |
Why?
| | Laparoscopy | 18 | 2022 | 219 | 3.570 |
Why?
| | Gastrostomy | 14 | 2023 | 67 | 3.340 |
Why?
| | Retrospective Studies | 51 | 2023 | 1337 | 2.240 |
Why?
| | Humans | 84 | 2023 | 6929 | 2.210 |
Why?
| | Male | 52 | 2023 | 3367 | 1.910 |
Why?
| | Child | 50 | 2023 | 3348 | 1.840 |
Why?
| | Enteral Nutrition | 7 | 2023 | 65 | 1.760 |
Why?
| | Female | 46 | 2023 | 3534 | 1.760 |
Why?
| | Infant | 34 | 2023 | 1449 | 1.640 |
Why?
| | Child, Preschool | 26 | 2023 | 1562 | 1.390 |
Why?
| | Postoperative Complications | 10 | 2023 | 202 | 1.360 |
Why?
| | Hepatoblastoma | 2 | 2019 | 7 | 1.300 |
Why?
| | Liver Neoplasms | 2 | 2019 | 16 | 1.290 |
Why?
| | Digestive System Surgical Procedures | 3 | 2019 | 38 | 1.050 |
Why?
| | Adolescent | 20 | 2023 | 2183 | 1.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 17 | 0.910 |
Why?
| | Embolization, Therapeutic | 3 | 2018 | 15 | 0.890 |
Why?
| | Hirschsprung Disease | 5 | 2021 | 56 | 0.850 |
Why?
| | Length of Stay | 12 | 2023 | 243 | 0.850 |
Why?
| | Infant, Newborn | 16 | 2021 | 826 | 0.820 |
Why?
| | Parents | 1 | 2023 | 152 | 0.810 |
Why?
| | Treatment Outcome | 16 | 2023 | 649 | 0.800 |
Why?
| | Patient Discharge | 3 | 2020 | 61 | 0.800 |
Why?
| | Clinical Protocols | 2 | 2019 | 33 | 0.780 |
Why?
| | Pediatrics | 3 | 2019 | 183 | 0.770 |
Why?
| | Pyloric Stenosis, Hypertrophic | 4 | 2023 | 23 | 0.770 |
Why?
| | Cryptosporidiosis | 1 | 2020 | 3 | 0.740 |
Why?
| | Immunocompromised Host | 1 | 2020 | 10 | 0.740 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2020 | 2 | 0.720 |
Why?
| | Hepatectomy | 2 | 2018 | 4 | 0.710 |
Why?
| | Blood Transfusion | 2 | 2018 | 13 | 0.680 |
Why?
| | Appendicitis | 3 | 2020 | 119 | 0.670 |
Why?
| | Sirolimus | 1 | 2019 | 8 | 0.670 |
Why?
| | Health Care Rationing | 2 | 2017 | 3 | 0.670 |
Why?
| | Tacrolimus | 1 | 2019 | 10 | 0.670 |
Why?
| | Tissue and Organ Procurement | 2 | 2017 | 17 | 0.660 |
Why?
| | Immunosuppressive Agents | 1 | 2019 | 32 | 0.660 |
Why?
| | Parenteral Nutrition, Total | 1 | 2018 | 7 | 0.660 |
Why?
| | Digestive System Abnormalities | 1 | 2018 | 7 | 0.650 |
Why?
| | Hyperbilirubinemia | 1 | 2018 | 9 | 0.650 |
Why?
| | Lung Diseases | 2 | 2017 | 23 | 0.640 |
Why?
| | Thrombelastography | 1 | 2018 | 2 | 0.630 |
Why?
| | Resuscitation | 1 | 2018 | 6 | 0.630 |
Why?
| | Hypoglycemia | 1 | 2018 | 31 | 0.630 |
Why?
| | Appendectomy | 3 | 2020 | 103 | 0.630 |
Why?
| | Abnormalities, Multiple | 2 | 2017 | 36 | 0.630 |
Why?
| | Liver | 4 | 2023 | 130 | 0.620 |
Why?
| | Organ Transplantation | 1 | 2017 | 6 | 0.600 |
Why?
| | Peritoneal Dialysis | 1 | 2019 | 156 | 0.600 |
Why?
| | Dextrocardia | 1 | 2017 | 3 | 0.590 |
Why?
| | Tomography, X-Ray Computed | 8 | 2018 | 130 | 0.580 |
Why?
| | Tracheoesophageal Fistula | 1 | 2017 | 27 | 0.580 |
Why?
| | Esophageal Atresia | 1 | 2017 | 33 | 0.580 |
Why?
| | Lung | 1 | 2017 | 66 | 0.570 |
Why?
| | Enterocolitis | 3 | 2021 | 36 | 0.560 |
Why?
| | Muscle, Smooth, Vascular | 4 | 1999 | 8 | 0.550 |
Why?
| | Choledochal Cyst | 1 | 2016 | 1 | 0.540 |
Why?
| | Jejunum | 1 | 2016 | 3 | 0.540 |
Why?
| | Duodenum | 1 | 2016 | 19 | 0.530 |
Why?
| | Ethanol | 3 | 1999 | 7 | 0.510 |
Why?
| | Multiple Trauma | 4 | 2005 | 12 | 0.490 |
Why?
| | Funnel Chest | 2 | 2005 | 59 | 0.490 |
Why?
| | Mediastinum | 2 | 2005 | 5 | 0.480 |
Why?
| | Gastroschisis | 3 | 2018 | 24 | 0.460 |
Why?
| | Liver Diseases | 2 | 2023 | 17 | 0.450 |
Why?
| | Pneumothorax | 4 | 2023 | 33 | 0.440 |
Why?
| | Hernia, Umbilical | 2 | 2021 | 15 | 0.430 |
Why?
| | Reoperation | 7 | 2022 | 64 | 0.410 |
Why?
| | Portal Vein | 3 | 2023 | 8 | 0.400 |
Why?
| | Intestinal Atresia | 2 | 2023 | 19 | 0.380 |
Why?
| | Endothelium, Vascular | 3 | 1999 | 6 | 0.380 |
Why?
| | Hernia, Inguinal | 2 | 2021 | 32 | 0.380 |
Why?
| | Nitric Oxide Synthase | 3 | 1999 | 6 | 0.380 |
Why?
| | Pylorus | 2 | 2010 | 12 | 0.360 |
Why?
| | Operative Time | 3 | 2022 | 31 | 0.350 |
Why?
| | Time Factors | 6 | 2018 | 263 | 0.340 |
Why?
| | Hepatic Artery | 2 | 2023 | 7 | 0.330 |
Why?
| | Thoracoscopy | 2 | 2006 | 29 | 0.330 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2005 | 41 | 0.320 |
Why?
| | Wounds, Nonpenetrating | 3 | 2023 | 62 | 0.320 |
Why?
| | Fundoplication | 2 | 2006 | 36 | 0.320 |
Why?
| | Adult | 11 | 2023 | 1199 | 0.300 |
Why?
| | Abdominal Injuries | 2 | 2023 | 29 | 0.280 |
Why?
| | Recurrence | 4 | 2023 | 121 | 0.280 |
Why?
| | Incidence | 7 | 2019 | 134 | 0.270 |
Why?
| | Pyelonephritis, Xanthogranulomatous | 1 | 2006 | 1 | 0.270 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2006 | 5 | 0.270 |
Why?
| | Brachial Plexus | 1 | 2005 | 3 | 0.270 |
Why?
| | Spleen | 2 | 2023 | 32 | 0.260 |
Why?
| | Follow-Up Studies | 6 | 2018 | 329 | 0.260 |
Why?
| | Thoracic Surgical Procedures | 1 | 2005 | 10 | 0.260 |
Why?
| | Pulsatile Flow | 3 | 1999 | 3 | 0.260 |
Why?
| | Anastomosis, Surgical | 3 | 2023 | 22 | 0.250 |
Why?
| | Surgical Wound Infection | 2 | 2021 | 48 | 0.250 |
Why?
| | Leg Injuries | 1 | 2004 | 1 | 0.240 |
Why?
| | Accidents, Home | 1 | 2004 | 6 | 0.240 |
Why?
| | Catheterization | 2 | 2023 | 30 | 0.240 |
Why?
| | Inpatients | 2 | 2020 | 43 | 0.230 |
Why?
| | Food, Formulated | 1 | 2023 | 4 | 0.230 |
Why?
| | Aorta, Thoracic | 2 | 2002 | 9 | 0.230 |
Why?
| | Vascular Diseases | 1 | 2023 | 8 | 0.230 |
Why?
| | Infant, Premature, Diseases | 1 | 2003 | 23 | 0.230 |
Why?
| | Renal Dialysis | 2 | 2023 | 110 | 0.230 |
Why?
| | Thrombosis | 1 | 2023 | 16 | 0.230 |
Why?
| | Duodenal Obstruction | 1 | 2023 | 15 | 0.220 |
Why?
| | Ulcer | 1 | 2003 | 1 | 0.220 |
Why?
| | Rectal Diseases | 1 | 2003 | 3 | 0.220 |
Why?
| | Intubation, Gastrointestinal | 2 | 2018 | 19 | 0.220 |
Why?
| | Hernia, Hiatal | 1 | 2003 | 7 | 0.220 |
Why?
| | Rectum | 2 | 2019 | 27 | 0.220 |
Why?
| | Algorithms | 2 | 2020 | 108 | 0.220 |
Why?
| | Gallbladder Diseases | 1 | 2003 | 13 | 0.220 |
Why?
| | Carotid Artery Injuries | 1 | 2002 | 1 | 0.220 |
Why?
| | Aneurysm, False | 1 | 2002 | 2 | 0.220 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2003 | 16 | 0.220 |
Why?
| | Kidney | 2 | 2019 | 94 | 0.220 |
Why?
| | Technetium Tc 99m Sulfur Colloid | 1 | 2002 | 4 | 0.220 |
Why?
| | Hernia | 1 | 2002 | 3 | 0.220 |
Why?
| | Splenectomy | 1 | 2002 | 8 | 0.220 |
Why?
| | GTP-Binding Proteins | 2 | 1999 | 7 | 0.210 |
Why?
| | Intestine, Small | 1 | 2002 | 15 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 2 | 2021 | 31 | 0.210 |
Why?
| | Blood Circulation | 2 | 1999 | 2 | 0.210 |
Why?
| | Intestinal Obstruction | 1 | 2002 | 20 | 0.210 |
Why?
| | Suture Techniques | 2 | 2018 | 11 | 0.210 |
Why?
| | Chest Tubes | 2 | 2023 | 24 | 0.210 |
Why?
| | Sutures | 2 | 2018 | 11 | 0.210 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 2 | 1999 | 2 | 0.210 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2023 | 18 | 0.210 |
Why?
| | Isoenzymes | 2 | 1999 | 23 | 0.210 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2001 | 3 | 0.210 |
Why?
| | Hemorrhage | 1 | 2001 | 22 | 0.200 |
Why?
| | Masks | 1 | 2021 | 7 | 0.200 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2021 | 27 | 0.200 |
Why?
| | Trauma Centers | 4 | 2023 | 44 | 0.200 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 5 | 0.190 |
Why?
| | Shock, Septic | 1 | 2021 | 5 | 0.190 |
Why?
| | Cells, Cultured | 6 | 2004 | 84 | 0.190 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2021 | 7 | 0.190 |
Why?
| | Numismatics | 1 | 2020 | 3 | 0.190 |
Why?
| | Acute Disease | 2 | 2020 | 77 | 0.190 |
Why?
| | Biliary Tract Diseases | 1 | 2020 | 5 | 0.190 |
Why?
| | Diarrhea | 1 | 2020 | 18 | 0.190 |
Why?
| | Graft Rejection | 1 | 2020 | 32 | 0.180 |
Why?
| | Foreign Bodies | 1 | 2020 | 23 | 0.180 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 50 | 0.180 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 3 | 0.180 |
Why?
| | Perioperative Care | 1 | 2019 | 11 | 0.170 |
Why?
| | Cisplatin | 1 | 2019 | 10 | 0.170 |
Why?
| | Steroids | 1 | 2019 | 16 | 0.170 |
Why?
| | Central Nervous System Depressants | 1 | 1998 | 1 | 0.170 |
Why?
| | Patient Safety | 1 | 2019 | 20 | 0.170 |
Why?
| | Peritonitis | 1 | 2019 | 56 | 0.170 |
Why?
| | Intestinal Volvulus | 1 | 2018 | 12 | 0.160 |
Why?
| | Aged | 4 | 2003 | 411 | 0.160 |
Why?
| | Intestinal Mucosa | 1 | 2019 | 38 | 0.160 |
Why?
| | Eosinophilia | 1 | 2019 | 27 | 0.160 |
Why?
| | Kansas | 1 | 2018 | 43 | 0.160 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 56 | 0.160 |
Why?
| | Kidney Diseases | 1 | 2019 | 71 | 0.160 |
Why?
| | Cell Movement | 1 | 1999 | 71 | 0.160 |
Why?
| | Rupture | 2 | 2016 | 4 | 0.160 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 114 | 0.160 |
Why?
| | Plasma | 1 | 2018 | 7 | 0.160 |
Why?
| | Malnutrition | 1 | 2018 | 8 | 0.160 |
Why?
| | Watchful Waiting | 1 | 2017 | 7 | 0.150 |
Why?
| | Animals | 8 | 2007 | 741 | 0.150 |
Why?
| | Herniorrhaphy | 3 | 2021 | 27 | 0.150 |
Why?
| | History, 20th Century | 1 | 2017 | 7 | 0.150 |
Why?
| | Waiting Lists | 1 | 2017 | 12 | 0.150 |
Why?
| | History, 21st Century | 1 | 2017 | 7 | 0.150 |
Why?
| | Global Health | 1 | 2017 | 14 | 0.150 |
Why?
| | Health Policy | 1 | 2017 | 14 | 0.150 |
Why?
| | Resuscitation Orders | 1 | 2017 | 2 | 0.150 |
Why?
| | Dopamine | 1 | 2017 | 6 | 0.150 |
Why?
| | Cardiotonic Agents | 1 | 2017 | 5 | 0.150 |
Why?
| | Middle Aged | 6 | 2006 | 645 | 0.150 |
Why?
| | Intraoperative Care | 1 | 2017 | 8 | 0.150 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2018 | 67 | 0.150 |
Why?
| | Specialties, Surgical | 1 | 2017 | 13 | 0.150 |
Why?
| | Infant Care | 1 | 2016 | 3 | 0.150 |
Why?
| | Rats | 7 | 2007 | 112 | 0.140 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2016 | 38 | 0.140 |
Why?
| | Neuroblastoma | 2 | 2006 | 14 | 0.140 |
Why?
| | Injury Severity Score | 4 | 2023 | 63 | 0.140 |
Why?
| | Cholangitis | 1 | 2016 | 2 | 0.140 |
Why?
| | Prospective Studies | 4 | 2023 | 547 | 0.130 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 4 | 0.130 |
Why?
| | Preoperative Care | 1 | 2015 | 28 | 0.130 |
Why?
| | Clinical Decision-Making | 1 | 2015 | 19 | 0.130 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 14 | 0.130 |
Why?
| | Thoracotomy | 2 | 2023 | 19 | 0.130 |
Why?
| | Diagnosis, Differential | 3 | 2006 | 78 | 0.120 |
Why?
| | Macrophages, Peritoneal | 2 | 2004 | 2 | 0.120 |
Why?
| | Patient Selection | 2 | 2004 | 34 | 0.120 |
Why?
| | Aged, 80 and over | 2 | 2003 | 168 | 0.110 |
Why?
| | Fluid Therapy | 2 | 2023 | 19 | 0.110 |
Why?
| | Cattle | 4 | 1999 | 24 | 0.110 |
Why?
| | Anal Canal | 2 | 2021 | 25 | 0.110 |
Why?
| | Outpatients | 2 | 2021 | 28 | 0.100 |
Why?
| | Fluoroscopy | 2 | 2020 | 20 | 0.100 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2007 | 15 | 0.100 |
Why?
| | Esophagus | 2 | 2020 | 28 | 0.100 |
Why?
| | Young Adult | 3 | 2021 | 641 | 0.100 |
Why?
| | Radiography | 2 | 2015 | 49 | 0.090 |
Why?
| | Perfusion | 2 | 1999 | 8 | 0.090 |
Why?
| | Critical Pathways | 1 | 2009 | 9 | 0.080 |
Why?
| | United States | 3 | 2019 | 670 | 0.080 |
Why?
| | Equipment Failure | 2 | 2006 | 10 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 5 | 1999 | 47 | 0.080 |
Why?
| | Patient Readmission | 2 | 2020 | 70 | 0.080 |
Why?
| | Graft Survival | 2 | 2008 | 33 | 0.080 |
Why?
| | Nephrectomy | 2 | 2007 | 15 | 0.080 |
Why?
| | Hepatic Veins | 1 | 2008 | 1 | 0.080 |
Why?
| | Hypertension, Portal | 2 | 1998 | 7 | 0.080 |
Why?
| | Living Donors | 1 | 2008 | 7 | 0.080 |
Why?
| | Databases, Factual | 2 | 2019 | 108 | 0.080 |
Why?
| | Stomach Diseases | 2 | 2004 | 2 | 0.080 |
Why?
| | Juxtaglomerular Apparatus | 1 | 2007 | 2 | 0.080 |
Why?
| | Interleukin-10 | 2 | 2004 | 5 | 0.080 |
Why?
| | Kidney Neoplasms | 1 | 2007 | 11 | 0.080 |
Why?
| | Biliary Atresia | 1 | 2007 | 2 | 0.070 |
Why?
| | Macaca mulatta | 1 | 2007 | 22 | 0.070 |
Why?
| | Hypertension | 1 | 2007 | 65 | 0.070 |
Why?
| | Rotavirus Infections | 1 | 2007 | 15 | 0.070 |
Why?
| | Age Factors | 2 | 2004 | 211 | 0.070 |
Why?
| | Thoracic Injuries | 2 | 2005 | 8 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2007 | 61 | 0.070 |
Why?
| | Mediastinal Neoplasms | 1 | 2006 | 5 | 0.070 |
Why?
| | Prevalence | 2 | 2023 | 150 | 0.070 |
Why?
| | Registries | 2 | 2023 | 93 | 0.070 |
Why?
| | Disease Transmission, Infectious | 1 | 2006 | 4 | 0.070 |
Why?
| | Risk Assessment | 2 | 2007 | 136 | 0.070 |
Why?
| | Herpes Simplex | 1 | 2006 | 10 | 0.070 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2006 | 1 | 0.070 |
Why?
| | Wounds and Injuries | 1 | 2006 | 43 | 0.070 |
Why?
| | Urinary Retention | 1 | 2006 | 6 | 0.070 |
Why?
| | Viscera | 1 | 2005 | 1 | 0.070 |
Why?
| | Hydrocephalus | 1 | 2006 | 8 | 0.070 |
Why?
| | Arm | 1 | 2005 | 3 | 0.070 |
Why?
| | Tissue Adhesions | 1 | 2006 | 9 | 0.070 |
Why?
| | Hospitals, Pediatric | 2 | 2004 | 186 | 0.070 |
Why?
| | Posture | 1 | 2005 | 9 | 0.070 |
Why?
| | Child Abuse | 1 | 2006 | 47 | 0.070 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 4 | 0.070 |
Why?
| | Colorado | 4 | 2006 | 9 | 0.060 |
Why?
| | NG-Nitroarginine Methyl Ester | 3 | 1999 | 4 | 0.060 |
Why?
| | Renal Veins | 1 | 2004 | 3 | 0.060 |
Why?
| | Wound Healing | 1 | 2004 | 8 | 0.060 |
Why?
| | Renal Artery | 1 | 2004 | 5 | 0.060 |
Why?
| | Leisure Activities | 1 | 2004 | 5 | 0.060 |
Why?
| | Interleukin-1 | 1 | 2004 | 5 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2004 | 8 | 0.060 |
Why?
| | Diaphragm | 1 | 2004 | 7 | 0.060 |
Why?
| | Granuloma, Plasma Cell | 1 | 2003 | 2 | 0.060 |
Why?
| | Infant, Low Birth Weight | 1 | 2003 | 14 | 0.060 |
Why?
| | Observational Studies as Topic | 1 | 2023 | 3 | 0.060 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2023 | 6 | 0.060 |
Why?
| | Aspirin | 1 | 2023 | 6 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 19 | 0.060 |
Why?
| | Anastomotic Leak | 1 | 2023 | 9 | 0.060 |
Why?
| | Anticoagulants | 1 | 2023 | 20 | 0.060 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 21 | 0.060 |
Why?
| | Diseases in Twins | 1 | 2003 | 1 | 0.060 |
Why?
| | Twins, Conjoined | 1 | 2003 | 1 | 0.060 |
Why?
| | Catheterization, Central Venous | 1 | 2003 | 20 | 0.060 |
Why?
| | Colitis, Ischemic | 1 | 2003 | 1 | 0.060 |
Why?
| | Ligation | 1 | 2003 | 4 | 0.060 |
Why?
| | Torsion Abnormality | 1 | 2003 | 2 | 0.060 |
Why?
| | Diverticulum | 1 | 2003 | 4 | 0.060 |
Why?
| | Emergencies | 1 | 2003 | 11 | 0.060 |
Why?
| | Arizona | 1 | 2023 | 9 | 0.060 |
Why?
| | Arkansas | 1 | 2023 | 9 | 0.060 |
Why?
| | Oklahoma | 1 | 2023 | 11 | 0.060 |
Why?
| | Cleft Lip | 1 | 2003 | 8 | 0.060 |
Why?
| | Texas | 1 | 2023 | 21 | 0.060 |
Why?
| | Cleft Palate | 1 | 2003 | 14 | 0.050 |
Why?
| | Comorbidity | 1 | 2003 | 56 | 0.050 |
Why?
| | Vascular Surgical Procedures | 1 | 2002 | 3 | 0.050 |
Why?
| | Accidents, Traffic | 1 | 2002 | 18 | 0.050 |
Why?
| | Angiography | 1 | 2002 | 10 | 0.050 |
Why?
| | Hematoma | 1 | 2002 | 1 | 0.050 |
Why?
| | Retroperitoneal Space | 1 | 2002 | 2 | 0.050 |
Why?
| | Radionuclide Imaging | 1 | 2002 | 6 | 0.050 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2002 | 4 | 0.050 |
Why?
| | Virulence Factors, Bordetella | 2 | 1999 | 2 | 0.050 |
Why?
| | Pertussis Toxin | 2 | 1999 | 2 | 0.050 |
Why?
| | Abdomen | 1 | 2022 | 14 | 0.050 |
Why?
| | Blotting, Western | 2 | 1999 | 18 | 0.050 |
Why?
| | Cell Division | 2 | 1999 | 12 | 0.050 |
Why?
| | Epoprostenol | 2 | 1999 | 2 | 0.050 |
Why?
| | Cyclooxygenase 1 | 2 | 1999 | 2 | 0.050 |
Why?
| | Cyclooxygenase 2 Inhibitors | 2 | 1999 | 3 | 0.050 |
Why?
| | Cyclooxygenase Inhibitors | 2 | 1999 | 4 | 0.050 |
Why?
| | Pancreatic Neoplasms | 1 | 2002 | 13 | 0.050 |
Why?
| | Cyclooxygenase 2 | 2 | 1999 | 5 | 0.050 |
Why?
| | Enzyme Inhibitors | 2 | 1999 | 22 | 0.050 |
Why?
| | Cryosurgery | 1 | 2002 | 14 | 0.050 |
Why?
| | Abdominal Muscles | 1 | 2001 | 1 | 0.050 |
Why?
| | Electrolytes | 1 | 2021 | 13 | 0.050 |
Why?
| | Biopsy | 2 | 2019 | 63 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2021 | 16 | 0.050 |
Why?
| | Membrane Proteins | 2 | 1999 | 53 | 0.050 |
Why?
| | Splanchnic Circulation | 2 | 1998 | 2 | 0.050 |
Why?
| | Hospitals | 1 | 2021 | 36 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1998 | 96 | 0.050 |
Why?
| | Child, Hospitalized | 1 | 2021 | 26 | 0.050 |
Why?
| | Risk Factors | 4 | 2004 | 490 | 0.050 |
Why?
| | BK Virus | 1 | 2021 | 3 | 0.050 |
Why?
| | Infusion Pumps | 1 | 2021 | 5 | 0.050 |
Why?
| | Mucormycosis | 1 | 2021 | 4 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2001 | 122 | 0.050 |
Why?
| | Esophagoscopy | 1 | 2020 | 11 | 0.050 |
Why?
| | Disease Management | 1 | 2021 | 36 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 98 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 1999 | 4 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 3 | 0.040 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 1999 | 1 | 0.040 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 1999 | 2 | 0.040 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1999 | 2 | 0.040 |
Why?
| | Enzyme Activation | 1 | 1999 | 12 | 0.040 |
Why?
| | Cell Adhesion | 1 | 1999 | 9 | 0.040 |
Why?
| | Kinetics | 1 | 1999 | 34 | 0.040 |
Why?
| | Cell Survival | 1 | 1999 | 20 | 0.040 |
Why?
| | Aorta | 1 | 1999 | 9 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 1999 | 9 | 0.040 |
Why?
| | Prostaglandins F | 1 | 1999 | 1 | 0.040 |
Why?
| | Radioimmunoassay | 1 | 1999 | 3 | 0.040 |
Why?
| | Blotting, Northern | 1 | 1999 | 5 | 0.040 |
Why?
| | Indomethacin | 1 | 1999 | 4 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2019 | 14 | 0.040 |
Why?
| | Thymidine | 1 | 1998 | 1 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 243 | 0.040 |
Why?
| | Heparin | 1 | 1998 | 6 | 0.040 |
Why?
| | Health Information Systems | 1 | 2018 | 5 | 0.040 |
Why?
| | RNA, Messenger | 1 | 1999 | 115 | 0.040 |
Why?
| | Receptors, Endothelin | 1 | 1998 | 1 | 0.040 |
Why?
| | Blood Vessels | 1 | 1998 | 5 | 0.040 |
Why?
| | Quality Improvement | 1 | 2019 | 60 | 0.040 |
Why?
| | Signal Transduction | 1 | 1999 | 133 | 0.040 |
Why?
| | Pouchitis | 1 | 1998 | 1 | 0.040 |
Why?
| | Proctocolectomy, Restorative | 1 | 1998 | 3 | 0.040 |
Why?
| | Colon | 1 | 1998 | 12 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2018 | 8 | 0.040 |
Why?
| | Ileum | 1 | 1998 | 15 | 0.040 |
Why?
| | Mesenteric Arteries | 1 | 1998 | 1 | 0.040 |
Why?
| | Hospital Costs | 1 | 2017 | 31 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2017 | 34 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 10 | 0.040 |
Why?
| | Ultrasonography | 2 | 2010 | 49 | 0.040 |
Why?
| | Neoplasm Staging | 2 | 2006 | 33 | 0.030 |
Why?
| | Survival Analysis | 2 | 2008 | 50 | 0.030 |
Why?
| | Prolapse | 2 | 2004 | 3 | 0.030 |
Why?
| | Suppuration | 1 | 2009 | 1 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 45 | 0.020 |
Why?
| | Functional Laterality | 1 | 2008 | 3 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 2 | 0.020 |
Why?
| | Hemodynamics | 2 | 1998 | 16 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2007 | 4 | 0.020 |
Why?
| | Renin-Angiotensin System | 1 | 2007 | 5 | 0.020 |
Why?
| | Blood Pressure Determination | 1 | 2007 | 14 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2007 | 47 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 2 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 25 | 0.020 |
Why?
| | Bilirubin | 1 | 2007 | 25 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2007 | 148 | 0.020 |
Why?
| | Rare Diseases | 1 | 2007 | 42 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2006 | 47 | 0.020 |
Why?
| | Simplexvirus | 1 | 2006 | 3 | 0.020 |
Why?
| | Prognosis | 1 | 2006 | 216 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2005 | 15 | 0.020 |
Why?
| | Craniocerebral Trauma | 1 | 2005 | 19 | 0.020 |
Why?
| | Survival Rate | 1 | 2005 | 83 | 0.020 |
Why?
| | Mice | 1 | 2007 | 339 | 0.020 |
Why?
| | Hypertension, Renovascular | 1 | 2004 | 4 | 0.020 |
Why?
| | Gastric Fistula | 1 | 2004 | 3 | 0.020 |
Why?
| | Cutaneous Fistula | 1 | 2004 | 3 | 0.020 |
Why?
| | Morbidity | 1 | 2004 | 13 | 0.020 |
Why?
| | Intestinal Perforation | 1 | 2004 | 11 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2004 | 25 | 0.020 |
Why?
| | Safety | 1 | 2004 | 14 | 0.020 |
Why?
| | Device Removal | 1 | 2004 | 18 | 0.020 |
Why?
| | Renal Insufficiency | 1 | 2004 | 10 | 0.020 |
Why?
| | Creatinine | 1 | 2004 | 52 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2004 | 10 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2004 | 20 | 0.010 |
Why?
| | Hospitalization | 1 | 2005 | 209 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2003 | 1 | 0.010 |
Why?
| | Hemothorax | 1 | 2003 | 3 | 0.010 |
Why?
| | Jugular Veins | 1 | 2003 | 3 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 103 | 0.010 |
Why?
| | Medical Errors | 1 | 2003 | 7 | 0.010 |
Why?
| | Radiography, Thoracic | 1 | 2003 | 12 | 0.010 |
Why?
| | Rectovaginal Fistula | 1 | 2003 | 2 | 0.010 |
Why?
| | Fetal Death | 1 | 2003 | 3 | 0.010 |
Why?
| | Abdominal Abscess | 1 | 2003 | 26 | 0.010 |
Why?
| | Vagina | 1 | 2003 | 10 | 0.010 |
Why?
| | Spine | 1 | 2003 | 7 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 68 | 0.010 |
Why?
| | Denervation | 1 | 2002 | 1 | 0.010 |
Why?
| | Intraoperative Period | 1 | 2002 | 1 | 0.010 |
Why?
| | Splanchnic Nerves | 1 | 2002 | 1 | 0.010 |
Why?
| | Jejunostomy | 1 | 2002 | 2 | 0.010 |
Why?
| | Palliative Care | 1 | 2002 | 17 | 0.010 |
Why?
| | APACHE | 1 | 2001 | 1 | 0.010 |
Why?
| | Postoperative Care | 1 | 2002 | 29 | 0.010 |
Why?
| | Critical Illness | 1 | 2001 | 22 | 0.010 |
Why?
| | Myosins | 1 | 1999 | 1 | 0.010 |
Why?
| | Physical Stimulation | 1 | 1999 | 1 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 1999 | 1 | 0.010 |
Why?
| | MAP Kinase Kinase 2 | 1 | 1999 | 1 | 0.010 |
Why?
| | Osteopontin | 1 | 1999 | 1 | 0.010 |
Why?
| | Mitogens | 1 | 1999 | 2 | 0.010 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 1999 | 2 | 0.010 |
Why?
| | Electric Stimulation | 1 | 1999 | 2 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 1999 | 2 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 2 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 2 | 0.010 |
Why?
| | Actins | 1 | 1999 | 5 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1999 | 7 | 0.010 |
Why?
| | Microfilament Proteins | 1 | 1999 | 12 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 1999 | 10 | 0.010 |
Why?
| | DNA | 1 | 1999 | 44 | 0.010 |
Why?
| | Citrulline | 1 | 1998 | 1 | 0.010 |
Why?
| | Deoxycholic Acid | 1 | 1998 | 1 | 0.010 |
Why?
| | Edetic Acid | 1 | 1998 | 1 | 0.010 |
Why?
| | Potassium Chloride | 1 | 1998 | 1 | 0.010 |
Why?
| | Acetylcholine | 1 | 1998 | 2 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1998 | 25 | 0.010 |
Why?
| | Endothelin-1 | 1 | 1998 | 1 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 1998 | 1 | 0.010 |
Why?
| | Receptor, Endothelin B | 1 | 1998 | 1 | 0.010 |
Why?
| | Vasoconstriction | 1 | 1998 | 3 | 0.010 |
Why?
| | Phenotype | 1 | 1999 | 256 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 1998 | 102 | 0.010 |
Why?
| | Adenomatous Polyposis Coli | 1 | 1998 | 24 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 1998 | 41 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|